摘要:
A compound of the formula: ##STR1## wherein R.sup.1 is lower alkyl optionally substituted with a substituent selected from the group consisting of acyl, hydroxy, lower alkoxy, aryl, lower alkylthio and a group of the formula: ##STR2## in which R.sup.5 is hydrogen or acyl and R.sup.6 is hydrogen or lower alkyl; aryl; or amino optionally substituted with substituent(s) selected from the group consisting of lower alkyl and acyl; andR.sup.2 is hydrogen or lower alkyl; orR.sup.1 and R.sup.2 are taken together with the attached nitrogen atom to form a heterocyclic group optionally substituted with substituent(s) selected from the group consisting of lower alkyl, hydroxy(lower )alkyl, lower alkoxy(lower)alkyl, acyl(lower)alkyl, oxo and acyl;R.sup.3 is hydrogen or lower alkyl; andR.sup.4 is lower alkyl;and its pharmaceutically acceptable salt, processes for the preparation thereof and pharmaceutical composition comprising the same.
摘要:
A compound of the formula: ##STR1## wherein R.sup.1 is lower alkyl optionally substituted aryl; or amino optionally substituted; andR.sup.2 is hydrogen or lower alkyl; orR.sup.1 and R.sup.2 are taken together with the attached nitrogen atom to form a heterocyclic group optionally substituted;R.sup.3 is hydrogen or lower alkyl; andR.sup.4 is lower alkyl;and its pharmaceutically acceptable salt, processes for the preparation thereof and pharmaceutical composition comprising the same
摘要:
This invention relates to new amino acid derivatives and pharmaceutically acceptable salts thereof, wherein the amino acid derivatives are useful in the treatment and/or prevention of hypertension, heart failure, renal diseases or glaucoma.
摘要:
The invention relates to treatment of diseases caused by thromboxane A.sub.2 comprising administering a compound ##STR1## wherein R.sup.1 is hydrogen or lower alkyl,R.sup.2 is carboxy(lower)alkyl or protected carboxy(lower)alkyl andR.sup.3 is --CH.dbd.N--R.sup.4 in which R.sup.4 is arylureido or arylthioureido andX is --O--,or a pharmaceutically acceptable salt thereof.
摘要:
The invention relates to novel compounds of the formula: ##STR1## wherein R.sup.1 is hydrogen, lower alkoxycarbonyl, phenylsulfonyl, phenylsulfonyl substituted with 1 to 3 substituent(s) selected from the group consisting of halogen, nitro, lower alkoxy, mono (or di or tri)halo(lower)alkyl and lower alkyl, phenylcarbamoyl, lower alkylsulfonyl, benzoyl or thienylsulfonyl;R.sup.2 is phenylsulfonyl or phenylsulfonyl substituted with 1 to 3 substituent(s) selected from the group consisting of halogen, lower alkyl, lower alkoxy and mono(or di or tri)halo(lower)alkyl,R.sup.3 is carboxy(lower)alkyl, lower alkyl substituted with carboxy and 1 to 3 halogen atom(s), esterified carboxy(lower)alkyl, carbamoyl(lower)alkyl, lower alkylsulfonylcarbamoyl(lower)alkyl, phenylsulfonylcarbamoyl(lower)alkyl, carboxyphenyl, esterified carboxyphenyl, carboxy, esterified carboxy, hydroxy(lower)alkyl, sulfino(lower)alkyl, phosphono(lower)alkyl, di(lower)alkoxyphosphoryl(lower)alkyl or halo(lower)alkyl,R.sup.7 is hydrogen or lower alkyl, andA is ##STR2## in which R.sup.8 is hydrogen or lower alkyl, or a pharmaceutically acceptable salt thereof, useful as therapeutic agents for thrombosis, asthma and nephritis.
摘要:
As a magnetic material for high frequencies provided in a high-frequency circuit component used as a high-frequency nonreciprocal circuit device, for example, a circulator and an isolator, a magnetic material which can be densely sintered at a relatively low temperature and has a reduced ferromagnetic resonance half width is provided. The magnetic material for high frequencies is primarily composed of yttrium iron-based garnet in which Ca substitutes for a part of Y site, and V substitutes for a part of Fe site, and does not substantially contain tetravalent nor pentavalent elements, other than V, or contains about 0.5% by weight or less of oxide of this element, and the ratio of Ca atoms to V atoms, Ca/V, falls within the range of 2.0
摘要:
This invention relates to heterocyclic derivatives useful for inhibiting the production of Interleukin-1 (IL-1) and tumor necrosis factor (TNF) and the like, which can be represented by the following formula: ##STR1## to a process for their production, to a pharmaceutical composition containing the same and to uses thereof.
摘要:
A composite magnetic material comprises a ferrite powder and a resin in which the powder comprises a spinel type ferrite including at least Ni and Co.
摘要:
A high-frequency circuit element which can be formed by firing simultaneously a microwave magnetic body and a hard magnetic body plate in the form of a laminate. The microwave magnetic body is made of calcium-vadium-iron and the hard magnetic body plate is made of strontium-iron, so that they have approximately the same firing temperature. They are separated by a screening film of palladium or platinum, which prevents the diffusion of strontium ions from the hard magnetic body plate to the microwave magnetic body. This constitution permits the simultaneous firing of the two components. The high-frequency circuit element is useful as a small, high-precision circulator, isolator, or inductor.